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Some species of the Baccharis genus have been shown to possess important biomedical properties, including cytotoxic activity.
In this study, we examined the cytotoxic effect of methanol extract from Baccharis obtusifolia (Asteraceae) in cancer cell lines of
prostate (PC-3), colon (RKO), astrocytoma (D-384), and breast (MCF-7). The methanolic extract displayed the largest substantial
cytotoxic effect in lines of colon cancer (RKO) and cerebral astrocytoma (D-384). Chromatographic purification of the B.
obtusifolia methanolic extract led to the isolation and identification of 5,4󸀠-dihydroxy-7-methoxyflavone (1) and 5-hydroxy-7,4󸀠-
dimethoxyflavone (2) compounds of the flavonoid type.
1. Introduction
Baccharis is the largest genus in the family Asteraceae,
with over 500 species distributed throughout North and
South America [1]. The largest American genus Baccharis
(Asteraceae) includes about 400 species. Of these species,
20% are locally used for medical purposes or, to a lesser
extent, as food or as rawmaterial for different local industries
[2]. The most prominent compounds in Baccharis are diter-
penoids, phenolic compounds like flavonoids and coumarins,
and triterpenoids, among others. Flavonoids are important
compounds isolated from a wide range of plants [3]. Diets
with a high flavonoid content are associated with positive
health effects and the prevention of several diseases [4]. Addi-
tionally, pharmacological studies have demonstrated the anti-
inflammatory effects [3] and antioxidant capacity [5] of sev-
eral flavonoids, and some flavonoids have been demonstrated
to possess cytotoxic, antifungal, antiviral, and antibacterial
properties [5–7]. The most prominent biomedical applica-
tions of the Baccharis obtusifolia H.B.K., commonly known
as “Chilca redonda,” include the treatment of rheumatism,
liver disease, wounds, and ulcers [1]. In the present study,
we performed a chemical composition analysis of the active
phytometabolites obtained from themethanolic extract of the
leaves ofBaccharis obtusifolia.We also evaluated the cytotoxic
activity of this extract on human cancer cell lines.
2. Materials and Methods
2.1. Preparation of the Extracts. The leaves from the Baccharis
obtusifolia species were collected on Villonaco (04∘01󸀠25󸀠󸀠
Lat. S, 79∘14󸀠45󸀠󸀠 Long. O, 2849m.a.s.l.) mountain of the
Loja Province of Ecuador. A sample specimen (PPN-as-
014) was deposited and identified in the Herbarium of
Departamento deQuı´mica of Universidad Te´cnica Particular
of Loja, Ecuador.
The collected leaves were subjected to a dehydration
process in a drying tray with airflow at a temperature of 32∘C
for seven days (final humidity: 6.8%).
To obtain the extract, we used 145 g of dried leaves and
cold methanol (4-5∘C). The method employed was dynamic
maceration for 5 hours in a light-free environment. This
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Figure 1: Structure of compounds isolated from Baccharis obtusifolia.
procedure was repeated three times. The extract was then
concentrated at 50mbar and 37∘C on a rotary evaporator
(Buchi R210; Switzerland, Flawil) and stored at 4∘C.
2.2. Isolation of Secondary Metabolites. The methanolic
extract (8.74 g) was filtrated to remove chlorophylls with a
reverse phase silica gel RP-18, 6.5 cm (CC,Merck, Darmstadt,
Germany) using specific mixtures of solvents: fraction 1
MeOH/H
2
O 85:15 (1000ml), fraction 2 MeOH/H
2
O 90:10
(250ml), fraction 3 100% MeOH (500ml), and fraction 4
100% dichloromethane (500ml).
To separate the components from the extract without
chlorophylls (fraction 1), a silica gel-60 F254 chromatography
column (CC, Merck) was used. Mixtures of hexane and ethyl
acetate solvents were used in polarity starting with hexane
(100%) to separate the compounds. Fractions of 200ml each
were collected using a vacuum pump, and the solvent was
then removed on a rotary evaporator and the residue was
recovered with dichloromethane.Thin layer chromatography
(TLC, Merck) was performed on each fraction to detect the
compounds. The compounds were visualized by spraying
the solutions with a mixture of vanillin, ethanol, and acid
sulfuric followed by heating on a hot plate. Fractions with
a similar profile were pooled and purified by conventional
procedures. Fraction 40-43 was crystallized using hexane and
ethyl acetate and fraction 70-79 was crystallized using hexane
and petroleum ether.
2.3. Characterization and Identification of Secondary Metabo-
lites. We followed the methods of Bailon-Moscoso et al.
(2016) [8]. Melting points were determined using a Fisher-
Johns apparatus.The 1Hand 13CNMR spectra were recorded
at 400MHz and 100MHz, respectively, on Varian 400MHz-
Premium Shielded equipment (Varian, Massachusetts, USA)
using tetramethylsilane as an internal reference. CDCl
3
and DMSO-d6 were used as solvents; chemical shifts were
expressed in parts per million (ppm) and coupling constants
(J) were reported in Hz. Mass spectra (MS) were determined
by a gas chromatograph (Agilent Technologies 6890 N,
Wilmington, DE) coupled to a mass spectrometer (Agilent
Technologies 5973 inert).
2.4. Cell Culture Procedures. Four human cancer cell lines
were used: PC-3, RKO, D-384, and MCF-7. The cells were
cultured in RPMI-1640 medium supplemented with 10%
fetal bovine serum (FBS, Invitrogen, Karlsruhe, Germany),
1% antibiotic-antimitotic solution (100 units/ml penicillin
G, 100 𝜇g/ml streptomycin, and 0.25 𝜇g/ml amphotericin
B, Gibco, Grand Island, NY), and 1% L-glutamine (2mM,
Gibco). The cells were incubated at 37∘C in a 5% CO
2
atmosphere. The viable cells were counted using the trypan
blue exclusion method in a hemocytometer [8].
2.5. Cell Viability Analysis via MTS Assay. The MTS (5-[3-
(carboxymethoxy)phenyl]-3-(4,5-dimethyl-2-thiazolyl)-2-
(4-sulfo-phenyl)-2H-tetrazolium inner salt) cell viability
assay was used to assess the inhibitory effects of the extracts
on the survival of human cancer cell lines. A total of 3–5
× 103 cells/well were seeded into 96-well plates and were
allowed to adhere for 24 h. The cells were then treated
with 50 𝜇g/ml of whole extract to yield a final volume of
2ml. Each concentration/assay was performed three times.
Dimethyl sulfoxide (DMSO) was used as a negative control
at a final concentration of 0.1% v/v, and 1 𝜇M doxorubicin
was used as a positive control. The cells were incubated with
the treatments for 48 h, after which 20𝜇L MTS (5mg/ml,
Aqueous One Solution Reagent, Gibco) was added and
further incubated for 4 h at 37∘C. The absorbance was
measured at 570 nm. The data obtained with cells treated
with DMSO were considered to represent 100% viability
[8]. In cell lines with an inhibition percentage over 30%,
doses of 15, 45, 60, 75, and 100 𝜇g/ml of methanolic extract
were applied, and the MTS assay was used to measure
the inhibitory concentration 50 (IC
50
) using nonlinear
regression.
2.6. Statistical Analysis. All of the data were reported as
means ± standard error of the mean (SEM) of three indepen-
dent experiments. The nonlinear regression was determined
by GraphPad Prism 5 (GraphPad Software, San Diego, CA).
3. Results
3.1. Isolation of Secondary Metabolites from B. Obtusi-
folia. From the methanolic extract without chlorophylls,
two representative fractions were obtained: F 70-79 eluted
in Hex:EtOAc 80:20, from which we isolated 80mg of
a white crystalline solid identified as sakuranetin (5,4󸀠-
dihydroxy-7-methoxyflavanone) (1), and the fraction F 43-
45 eluted in Hex:EtOAc 90:10, from which we isolated
11.2mg of a yellow crystalline solid identified as 5-hydroxy-
7,4󸀠-dimethoxyflavone (2) (Figure 1). All of the compounds
were identified based on physical and spectroscopic data via
comparisons with the literature [9–11].
International Journal of Medicinal Chemistry 3
Table 1: Effect of Baccharis obtusifolia extract on the growth of human cancer cell lines.
Treatment
% of inhibition ± SEMa
Human cancer cell lines
MCF-7 (breast cancer) PC3 (prostate cancer) RKO(colon cancer) D-384 (astrocytoma)
Methanolic extract 20.2 ± 0.7 18.3 ± 1.2 89.2 ± 1.3 60.6 ± 0.5
Doxorubicin (1𝜇M) 40.9 ± 7.4 54.8 ± 1.9 89.2 ± 4.0 79.0 ± 4.6
aMean and standard error (SEM) of at least three independent experiments. Control cells were considered to exhibit 100% viability.
Table 2: Half maximal inhibitory concentration (IC
50
) of the compounds isolated from Baccharis obtusifolia on cancer cell lines.
Compound
IC
50
± SEMa (𝜇M)
MCF-7
(breast cancer)
PC-3
(prostate cancer)
RKO
(colon cancer)
D-384
(astrocytoma)
5,4'-dihydroxy-7-methoxyflavone (1) >100 >100 68.11 ± 1.08 >100
5-hydroxy-7,4󸀠-dimethoxyflavone (2) >100 >100 34.30 ± 1.34 >100
aEach datum is given as the mean and its standard error (SEM) of at least three independent experiments.
3.2. Characterization and Identification of Secondary Metabo-
lites. Physical and spectroscopic constants from 5,4󸀠-dihy-
droxy-7-methoxyflavone (1): m.p. 240–243∘C, EIMS m/z (%)
286 (M+, 100), 269 (36), 241 (16), 167 (13), 166 (14), 138 (14),
128 (16), 121 (7), 118 (10). 1HNMR (DMSO-d
6
) 𝛿 ppm: 2.8 (1H,
dd), 3.1 (1H, dd), 3.89 (3H, s), 6.40 (1H, d, J=2.3Hz), 6.79 (1H,
d, J=2.3Hz), 6.85 (1H, s), 6.96 (2H, d, J=9.3Hz), 7.98 (2H, d,
J=9.3Hz), 12.95 (1H, s,) 13C NMR (DMSO-d
6
) 𝛿 ppm: 79 (C-
2) 43.1 (C-3) 196.0 (C-4) 164.1 (C-5) 95.1 (C-6) 168.0 (C-7)
94.2 (C-8) 162.8 (C-9) 103.5 (C-10) 130.5 (C-1’) 128.0 (C-2’)
114.2 (C-3’) 156.1 (C-4’) 115.6 (C-5’) 128.0 (C-6’) 55.6 (OCH
3
-
7).
Physical and spectroscopic constants from 5-hydroxy-
7,4󸀠-dimethoxyflavone (2): m.p. 160–163∘C. EIMS m/z (%)
298 (M+, 100), 269 (28), 255 (14), 166 (11), 138 (16), 135 (10),
132 (16). 1H NMR (CDCI
3
) 𝛿 ppm: 3.89, 3.90 (3H each, s),
6.37 (1H, d, J= 2.4Hz), 6.49 (1H, d, J=2.4Hz), 6.58 (1H, s),
7.02 (2H, d, J=9.3Hz), 7.85 (2H, d, J=9.3Hz), 12.80 (1H, s).
13C NMR (CDCl
3
) 𝛿 ppm: 164.0 (C-2) 104.3 (C-3) 182.4 (C-
4) 165.4 (C-5) 98.0 (C-6) 165.4 (C-7) 92.6 (C-8) 162.1 (C-9)
104.3 (C-10) 123.5 (C-1’) 128.0 (C- 2’) 114.4 (C-3’) 157.6 (C-4’)
114.5 (C-5’) 128.3 (C-6’) 55.6 (OCH
3
7’) 55.7 (OCH
3
-4’).
3.3. Cytotoxic Effects of Methanolic Extract and Isolated
Compounds on Human Cancer Cell Lines. The effect of the
methanolic extract on cell viability was determined via an
MTS assay using human cancer cell lines treated for 48 h
with thewhole extract ofB. obtusifolia (50 𝜇g/ml).The extract
exhibited a strong inhibitory effect on RKO 89.2%, as in D-
384 cells with 60.6%. However, the MCF-7 and PC3 cell lines
exhibited moderate inhibitory activity with 20.2% and 18.3%,
respectively (Table 1).
Compounds 1 and 2 presented higher IC
50
to 100 𝜇M
for MCF-7, D-384, and PC-3 cell lines; for the RKO cell
line, we obtained IC
50
of 68.11 𝜇M (19.48𝜇g/ml) and 34.30
𝜇M (10.22 𝜇g/ml), for compounds 1 and 2, respectively.
Compounds 1 and 2 were specific for the RKO line, and
compound 2 was more effective than compound 1 (Table 2).
4. Discussion
The species belonging to the Asteraceae family are char-
acterized by their abundant biological activity [12], which
results from their chemical composition, including secondary
metabolites such as terpenes, diterpenes, flavonoids, and
coumarins [13]. In the present study, two flavonoid com-
pounds were isolated, 5,4󸀠-dihydroxy-7-methoxyflavanone
(1) and 5-hydroxy-7,4󸀠-dimethoxyflavone (2). These com-
pounds have been identified for the first time in Baccharis
obtusifolia, but they have been reported in other species: com-
pound 1 in Chromolaena subscandens [14], Trixis vauthieri
[15], and Trigona spinipes [16] and compound 2 in Baccharis
polycephala [4], Thymus vulgaris [9], Combretum erythro-
phyllum [17], Kaempferia parviflora [18], and Boesenbergia
pandurata [19].
Our evaluation of the biological activity of methanolic
extract revealed a high percentage of inhibition in RKO cell
lines (89.2%), followed by D-384 cells (60.6%). This activity
can be attributed to the presence of flavonoids in the extract.
Some flavonoids act on these stages in very different cell
types, which may lead to the use of these compounds as
cytostatic agents in the later stages of carcinogenesis rather
than as early-stage preventive elements [20, 21].
IC
50
of flavonoids 1 and2 shows similar values to the other
compounds of the same type [22–24]. Numerous studies have
suggested that flavonoids may play a protective role in the
prevention of cancer, coronary heart diseases, bone loss, and
many other age-related diseases [21]. The activity found in
the methanol extract may be due to the presence of isolated
flavonoids.
Chemically, flavones are substances of phenolic nature
and are characterized by having two benzene aromatic rings
united by a bridge with three carbon atoms. They have the
general structure C
6
-C
3
-C
6
, which may form a third ring.
Natural flavonoids are often present in at least three phenolic
hydroxyls [25]. The NMR 1H data from compounds 1 and
2 show a substitution pattern “para” in the ring B [26];
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substitutions in these flavones are found in the C-4󸀠 position
of the B ring; in the case of compound 1, the substituent
corresponds to a hydroxyl group (OH), and for compound
2, the substituent corresponds to a methoxy group (OCH
3
).
In the NMR data of 13C from compound 1 in the aliphatic
zone 𝛿 (55.6 ppm), there appears a signal that belongs to a
methoxy group. The signal in 𝛿 (43.1 ppm) is assigned to
C-3 [26] and the signal in 103.5 ppm is assigned to C-10 of
hydroxylated flavones, which are included in the structure
of our compound and confirmed in the 1H NMR spectrum.
The spectral data of compound 2 show two signals in 𝛿
(55.6–55.7 ppm) belonging to twomethoxy groups present in
this structure, and these two groups are also observed in the
1H NMR spectrum.
Flavonoids have characteristics that make them attrac-
tive for anticancer research. They act in vitro via various
mechanisms in the oncogenic process, which renders them
possible useful agents in the early stages of cancer or in
the inhibition of later stages of progression or invasion.
This activity may be explained by studying the Structure-
Activity Relationship (SAR) between several flavonoids and
cancer [27]. An example is the study of Zhang (2005) which
focused on activity of flavonoids and breast cancer cells. This
author found that the double bond between C-2 and C-
3, the ring B connected to C-2, the hydroxyl group in C-
5, the nonhydroxylation in C-3, and the presence of apolar
substituents in C-6, C-7, C-8, or C-4󸀠 were structural char-
acteristics important for the interaction between flavonoids
and breast cancer resistance protein (BCRP) [21].The structure
5-hydroxy-7,4󸀠-dimethoxyflavone (2) possesses important
structural characteristics like the double bond between C-2
and C-3 and the presence of an OH group at the 5-position
and the carbonyl group at the 4-position. Previous studies
have suggested that the position, number, and substitution of
hydroxyl groups in rings A and B, as well as the saturation
in the C2-C3 bond, may be important factors that increase
the cytotoxic or antiproliferative activities of flavonoids [28],
which would explain the cytotoxic action of 5-hydroxy-7,4󸀠-
dimethoxyflavone in RKO cells. On the contrary, the flavone
sakuranetin (1) does not exhibit the double bond at C-2 and
C-3, which inmono- or dihydroxylated flavones results in the
loss of cellular growth inhibitory activity [28]. It would be
interesting to continue studies of this species and the isolated
compounds. Additional studies of themolecularmechanisms
underlying the effect of these secondary metabolites on
cancer cell survival are accordingly necessary.
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